They described that c‐kit was overexpressed in 53.7% of cases for superficially spreading melanoma, indicating that c‐kit is overexpressed primarily in early stages of disease, although there was no statistically significant difference in the survival between the c‐kit‐positive and c‐kit‐negative groups.12 This evidence concerns the gene KIT and melanoma.